Anavex Life Sciences Corp (AVXL)

[RedShoulder]

the FDA will be meeting with the International Rett Syndrome Foundation on March 11th to discuss new drug approvals. What are the chances that the Rett Foundation will be promoting (demanding!) Anavex's drug for approval?

"The International Rett Syndrome Foundation and the Rett Syndrome Research Trust are hosting an Externally-Led Patient-Focused Drug Development meeting and invite you to attend. By signing up you will receive the link to a public meeting with the US Food and Drug Administration and other stakeholders including drug developers, where you will be able to share the impact of Rett syndrome on your child and family, your perspective on possible treatments, and how symptom improvements would affect your and your child’s quality of life. The FDA is especially interested in hearing from parents, caregivers, and family members from the United States."

abew4me, thanks for posting this information. I have no doubt that by March 11th that the parents and care givers of those Rett patients in trials seeing the obvious improvements by that future time as compared to now, and will be urging the FDA to give approval as fast as possible. The FDA will listen, especially giving the fact that these girls are suffering terribly and facing eventual early death.

Plus two other facts; there are currently no other drugs available to help, and A2-73 Blarcamesine is very safe, and that is always the most important consideration the FDA reviews and considers when approving any drug.

Nice information post abew4me, this will be an important event for helping to get Rett FDA approval as fast as possible, likely more important than most realize.